{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:28:21Z","timestamp":1786393701798,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370698"],"award-info":[{"award-number":["32370698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503704"],"award-info":[{"award-number":["82503704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82321003"],"award-info":[{"award-number":["82321003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173128"],"award-info":[{"award-number":["82173128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","award":["CKS-SYSUCC-2024009"],"award-info":[{"award-number":["CKS-SYSUCC-2024009"]}],"id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","award":["YTP-SYSUCC-0029"],"award-info":[{"award-number":["YTP-SYSUCC-0029"]}],"id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1302100"],"award-info":[{"award-number":["2021YFA1302100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763801"],"award-info":[{"award-number":["2024M763801"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZB20240907"],"award-info":[{"award-number":["GZB20240907"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.scib.2026.06.022","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:04:13Z","timestamp":1780934653000},"page":"3713-3730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pancancer pro-angiogenic atlas unravels tumor-educated pericyte-augmented anti-angiogenic resistance"],"prefix":"10.1016","volume":"71","author":[{"given":"Yongqiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junteng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Xian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2026.06.022_b0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.scib.2026.06.022_b0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.scib.2026.06.022_b0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.scib.2026.06.022_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions","volume":"17","author":"Vasudev","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.scib.2026.06.022_b0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells8091102","article-title":"Trends and challenges in tumor anti-angiogenic therapies","volume":"8","author":"Jaszai","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.scib.2026.06.022_b0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2020.00221","article-title":"Resistance mechanisms to anti-angiogenic therapies in cancer","volume":"10","author":"Haibe","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.scib.2026.06.022_b0035","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-09-0095","article-title":"Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy","volume":"15","author":"Ebos","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2026.06.022_b0040","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2026.06.022_b0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","article-title":"Cancer lipid metabolism confers antiangiogenic drug resistance","volume":"28","author":"Iwamoto","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.scib.2026.06.022_b0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303740120","article-title":"KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas","volume":"120","author":"Hosaka","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2026.06.022_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400244","article-title":"PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors","volume":"1","author":"Iwamoto","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.scib.2026.06.022_b0060","doi-asserted-by":"crossref","first-page":"e9266","DOI":"10.15252\/emmm.201809266","article-title":"Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy","volume":"11","author":"Uribesalgo","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.scib.2026.06.022_b0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1634\/theoncologist.2012-0068","article-title":"Overcoming resistance to antiangiogenic therapies","volume":"17","author":"Tejpar","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.scib.2026.06.022_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.scib.2026.06.022_b0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.scib.2026.06.022_b0080","first-page":"52","article-title":"Recent developments in application of single-cell RNA sequencing in the tumour immune microenvironment and cancer therapy","volume":"9","author":"Li","year":"2022","journal-title":"Mil Med Res"},{"key":"10.1016\/j.scib.2026.06.022_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.omto.2021.04.001","article-title":"Single-cell RNA sequencing in cancer: applications, advances, and emerging challenges","volume":"21","author":"Sun","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.scib.2026.06.022_b0090","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.scib.2026.06.022_b0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/2326-6066.CIR-20-1026","article-title":"Single-cell analysis of the pan-cancer immune microenvironment and scTIME portal","volume":"9","author":"Hong","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.scib.2026.06.022_b0105","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.06.022_b0110","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1002\/ctm2.1501","article-title":"Pan-cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response","volume":"13","author":"Zheng","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.scib.2026.06.022_b0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","article-title":"Tumour vasculature at single-cell resolution","volume":"632","author":"Pan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.scib.2026.06.022_b0120","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.06.022_b0125","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"10.1016\/j.scib.2026.06.022_b0135","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.scib.2026.06.022_b0140","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/2159-8290.CD-22-1368","article-title":"Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer","volume":"13","author":"Weng","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.scib.2026.06.022_b0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","article-title":"An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic candidates","volume":"37","author":"Goveia","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0150","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.devcel.2021.06.021","article-title":"Specialied endothelial tip cells guide neuroretina vascularization and blood-retina-barrier formation","volume":"56","author":"Zarkada","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12079-019-00511-z","article-title":"The endothelial tip-stalk cell selection and shuffling during angiogenesis","volume":"13","author":"Chen","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.scib.2026.06.022_b0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","article-title":"Differential abundance testing on single-cell data using k-nearest neighbor graphs","volume":"40","author":"Dann","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"Suppl 1","key":"10.1016\/j.scib.2026.06.022_b0165","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/annonc\/mdw093","article-title":"Anti-angiogenic agents in ovarian cancer: past, present, and future","volume":"27","author":"Monk","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.scib.2026.06.022_b0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/lio2.742","article-title":"Diagnosis of lymph node metastasis in head and neck squamous cell carcinoma using deep learning","volume":"7","author":"Tang","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.scib.2026.06.022_b0175","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104063","article-title":"Stromal cell diversity associated with immune evasion in human triple-negative breast cancer","volume":"39","author":"Wu","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.scib.2026.06.022_b0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.scib.2026.06.022_b0185","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0190","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.2200154","article-title":"Single-cell analysis reveals the range of transcriptional states of circulating human neutrophils","volume":"209","author":"Wigerblad","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.scib.2026.06.022_b0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41467-017-02610-0","article-title":"Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours","volume":"9","author":"Sidibe","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.06.022_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","article-title":"The role of monocytes in angiogenesis and atherosclerosis","volume":"63","author":"Jaipersad","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.scib.2026.06.022_b0205","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","article-title":"Immune phenotypic linkage between colorectal cancer and liver metastasis","volume":"40","author":"Liu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/cancers14030536","article-title":"The good, the bad, and the ugly: neutrophils, angiogenesis, and cancer","volume":"14","author":"Ozel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.scib.2026.06.022_b0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00441-016-2377-y","article-title":"Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney","volume":"365","author":"Muhl","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.scib.2026.06.022_b0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2015.11.047","article-title":"Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma","volume":"381","author":"Craven","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.scib.2026.06.022_b0225","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/cancers13051031","article-title":"Angiogenesis inhibitors for colorectal cancer. A review of the clinical data","volume":"13","author":"Hansen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.scib.2026.06.022_b0230","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gutjnl-2022-327913","article-title":"Novel TCF21(high) pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.scib.2026.06.022_b0235","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.06.022_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109253","article-title":"Tumor vessel co-option probed by single-cell analysis","volume":"35","author":"Teuwen","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.scib.2026.06.022_b0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125940","article-title":"Deficiency of Notch signaling in pericytes results in arteriovenous malformations","volume":"5","author":"Nadeem","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.scib.2026.06.022_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.08.048","article-title":"Lactate lactylation in neural pathophysiology: bridging metabolism and neurodegeneration","volume":"585","author":"Cao","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.scib.2026.06.022_b0255","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1038\/s41467-022-33052-y","article-title":"Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast","volume":"13","author":"Geldhof","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.06.022_b0260","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1002\/jcp.27414","article-title":"Challenges facing antiangiogenesis therapy: the significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies","volume":"234","author":"Mahdi","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.scib.2026.06.022_b0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrc2894","article-title":"Targeting the ANGPT-TIE2 pathway in malignancy","volume":"10","author":"Huang","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.scib.2026.06.022_b0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-230X(06)97009-2","article-title":"Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis","volume":"97","author":"Cao","year":"2007","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.scib.2026.06.022_b0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.scib.2026.06.022_b0280","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-09-1977","article-title":"Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth","volume":"70","author":"Hashizume","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.scib.2026.06.022_b0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrclinonc.2009.63","article-title":"Biomarkers of response and resistance to antiangiogenic therapy","volume":"6","author":"Jain","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.scib.2026.06.022_b0290","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-09-0274","article-title":"Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition","volume":"8","author":"Rapisarda","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.scib.2026.06.022_b0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3727\/096504014X13983417587366","article-title":"HIF-1 dimerization inhibitor acriflavine enhances antitumor activity of Sunitinib in breast cancer model","volume":"22","author":"Yin","year":"2014","journal-title":"Oncol Res"},{"key":"10.1016\/j.scib.2026.06.022_b0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpedsurg.2012.10.016","article-title":"HIF-1alpha activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts","volume":"48","author":"Hartwich","year":"2013","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.scib.2026.06.022_b0305","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.scib.2026.06.022_b0310","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s00432-021-03701-8","article-title":"Targeting tumor vascularization: promising strategies for vascular normalization","volume":"147","author":"Zheng","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.scib.2026.06.022_b0315","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.semcancer.2009.05.001","article-title":"Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance","volume":"19","author":"Cao","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.scib.2026.06.022_b0320","doi-asserted-by":"crossref","first-page":"E9635","DOI":"10.1073\/pnas.1703431114","article-title":"Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production","volume":"114","author":"Nakamura","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2026.06.022_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2025.100087","article-title":"Transforming the landscape of cancer treatment with seven promising novel therapies: evolution and future perspectives","volume":"2","author":"Miao","year":"2025","journal-title":"Med Plus"},{"key":"10.1016\/j.scib.2026.06.022_b0330","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-024-01963-7","article-title":"A review of the clinical efficacy of FDA-approved antibody\u2012drug conjugates in human cancers","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.scib.2026.06.022_b0335","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","article-title":"Cancer therapy with antibodies","volume":"24","author":"Paul","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.scib.2026.06.022_b0340","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody-drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.scib.2026.06.022_b0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1634\/theoncologist.2016-0479","article-title":"A phase II, randomized, double-blind, placebo-controlled study of Simtuzumab in combination with FOLFIRI for the second-line treatment of metastatic KRAS mutant colorectal adenocarcinoma","volume":"22","author":"Hecht","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.scib.2026.06.022_b0350","first-page":"1639","article-title":"A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer","volume":"9","author":"Scott","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2026.06.022_b0355","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors","volume":"111","author":"Bergers","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2026.06.022_b0360","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ncb1288","article-title":"PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival","volume":"7","author":"Song","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.scib.2026.06.022_b0365","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.11.024","article-title":"Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by MET signaling pathway","volume":"21","author":"Cooke","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scib.2026.06.022_b0370","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI25705","article-title":"Pericytes limit tumor cell metastasis","volume":"116","author":"Xian","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2026.06.022_b0375","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1158\/0008-5472.CAN-23-1356","article-title":"A cell surface-binding antibody atlas nominates a MUC18-directed antibody-drug conjugate for targeting melanoma","volume":"83","author":"Shi","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.scib.2026.06.022_b0380","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1538-7445.AM2024-739","article-title":"Abstract 739: AMT-253, a first-in-class MUC18-targeting antibody-drug conjugate, for the treatment of MUC18-positive solid tumors","volume":"84","author":"Shi","year":"2024","journal-title":"Cancer Research"},{"key":"10.1016\/j.scib.2026.06.022_b0385","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","article-title":"Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis","volume":"31","author":"Rohlenova","year":"2020","journal-title":"Cell Metab"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326006584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326006584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:32:13Z","timestamp":1786390333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927326006584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":77,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2095927326006584"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2026.06.022","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancancer pro-angiogenic atlas unravels tumor-educated pericyte-augmented anti-angiogenic resistance","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2026.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}